Clinical trial
Multi-centre Evaluation of Carbapenemase-producing Enterobacterales (CPE) Prevalence and Transmission Dynamics, Recommendations on Screening Strategies, and Health Economics Outcomes Research Impact to Inform Policy Change
NCT07663110 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multi-centre Evaluation of Carbapenemase-producing Enterobacterales (CPE) Prevalence and Transmission Dynamics, Recommendations on Screening Strategies, and Health Economics Outcomes Research Impact to Inform Policy Change
- Lead sponsor
- Imperial College London
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- August 1, 2026
- Completion date
- March 31, 2028
- Enrollment
- 16,000 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
carbapenem-resistant enterobacteriaceae, colonisation